Genzyme Enters Multi-Year MS Research Collaboration with Cleveland Clinic’s Academic Medical Center
Cambridge, Massachusetts based biotech firm GenzymeĀ has formed a new research collaboration with Cleveland Clinic of Cleveland, Ohio with a focus on developing new therapeutic approaches to the treatment of Multiple Sclerosis (MS). More than 2.3 million people worldwide have been diagnosed with MS, including what is believed…